- Lobbying
- for AND molecular AND pathology
Lobbying Arrangements Results for 'For Molecular Pathology'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Medicare policy issues relating to consolidated billing for lab services. |
RedPath Integrated Pathology, Inc.
|
KING & SPALDING LLP | |||
Details Advanced molecular diagnostic policy. Laboratory and pathology coverage and payment issues. |
Caris Life Sciences, Inc.
|
THE MCMANUS GROUP | |||
Details S 1000/HR 2377, Saving Access to Laboratory Services Act |
Association for Molecular Pathology
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs S.2140: Patent Eligibility Restoration Act of 2023 |
Association for Molecular Pathology
|
iPolicy Solutions | |||
Details Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No ... |
Association for Molecular Pathology
|
HealthFutures, LLC | |||
Details Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding. H.R. 3005: Medical Test... |
LIFE TECHNOLOGIES CORPORATION
|
in-house lobbying |